Report ID: 10352405 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Thyroid Disorder Market Scope
|
Base Year |
2021 |
|
Forecast Year |
2022-2031 |
|
CAGR |
~5% |
|
Base Year Market Size (2021) |
~ USD 1.5 Billion |
|
Forecast Year Market Size (2031) |
~ USD 2.6 Billion |
Global Thyroid Disorder Market Size, Forecast, and Trend Highlights Over 2022 - 2031
The global thyroid disorder market is estimated to garner a revenue of nearly USD 2.6 billion by the end of 2031 by growing at a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. Further, the market generated a revenue of close to USD 1.5 billion in the year 2021. This growth can be attributed to an increase in the number of people afflicted with various thyroid gland disorders. It has been estimated that more than 10 percent of the U.S. population will develop a thyroid condition during their lifetime and around 23 million Americans already have some form of thyroid disease.
GET A SAMPLE COPY OF THIS REPORT
The thyroid gland, which is a butterfly-shaped gland in the neck, helps control the metabolism of the human body. If it is underactive, it leads to weight gain, constipation, or fatigue, which is also technically known as hypothyroidism. If it is overactive, it leads to weight loss, sweating, a faster heartbeat, and a feeling of nervousness or moodiness, also known as hyperthyroidism.
Thyroid disorders can range from a small, harmless goiter (enlarged gland) that needs no treatment to life-threatening cancer. As per the American Cancer Society’s estimates for thyroid cancer in the United States for 2022, there were about 43,800 new cases of thyroid cancer and around 2,230 deaths due to the same. Hence, there is huge scope for the diagnosis and treatment of thyroid disorders in the global market over the forecast period.
Global Thyroid Disorder Market: Growth Drivers and Challenges
Growth Drivers
-
High Incidence of Thyroid Disorders – Thyroid disorders are more common in women than in men affecting 1 in 8 women, according to the Office on Women’s Health, a part of the US Department of Health & Human Services. It affects women’s menstrual cycle, pregnancies, and menopause. Hypothyroidism and hyperthyroidism are common thyroid disorders that create potentially devastating health consequences that affect people worldwide.
-
Increase in the Number of Patients with Iodine Deficiencies – Although preventive measures such as the use of iodized salt have been undertaken all across the globe. People from many parts of the world still do not get enough iodine through their diet, and iodine deficiency continues to be an important public health concern affecting approximately 35% of the world’s population.
-
Development of Effective Combination Drug Therapies to Treat Thyroid Gland Disorders – Beta-blockers, anti-thyroid drugs, radioactive iodine treatment (RAI), thyroid hormone replacement therapy, and thyroid surgery (thyroidectomy) or a combination of these treatments are currently in trend to treat thyroid gland disorders, thus expanding the thyroid disorder market size. For instance, radioactive iodine therapy is a safe and effective way of treating toxic nodular goiter with a success rate of 85-100% of patients, according to a study published in Pakistan by the National Institutes of Health (NIH) in 2018.
-
Increase in Awareness Amongst Patients in Terms of Early Screening and the Presence of Modern Diagnostic Facilities- The use of sensitive diagnostic procedures, such as CT or MRI scans (done for other medical problems), can detect incidental small thyroid nodules that might not otherwise have been found in the past. Mandatory screening of newborns for congenital hypothyroidism and early treatment have prevented mental retardation and other ailments in the long run. As of 2022, there are more than 29,000 diagnostic and medical laboratories in the United States.
-
Growing Number of Clearances and Product Launches by Leading Market Players Have Propelled Market Growth- Food and Drug Administration (FDA) has approved Levothyroxine for the treatment of thyroid gland disorders. Desiccated thyroid extract (DTE), another type of therapy has also been approved by the FDA and is available globally under different brand names.
Challenges
-
Side Effects of Some of the Drugs Used for Treatment of the Disease
-
Lack of Insurance Coverage in Several Developed Nations for Thyroid Testing
-
Increased Availability of Low-Cost Generic Drugs
The global thyroid disorder market is segmented and analyzed for demand and supply by disorder type into hypothyroidism and hyperthyroidism. Of them, the hypothyrohvidism segment is projected to hold the highest market share during the forecast period, owing to the fact that it is the most commonly occurring disorder of the thyroid gland. Around 5 out of 100 Americans aged 12 years and older have hypothyroidism with the affliction more common in women than in men and in older people than the young, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A high prevalence of iodine deficiency all over the world is another factor that is predicted to inflate the size of the segment in the coming years.
Global Thyroid Disorder Market Regional Synopsis
Regionally, the global thyroid disorder market is categorized into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regions. Amongst these, the market in North America is projected to hold the largest market share during the forecast period due to the presence of well-established healthcare industry in the region. The other factors that influence the growth of the market in North America are favorable reimbursement policies and the high prevalence of autoimmune thyroid disorders such as Graves’ disease and Hashimoto’s disease. According to one of the statistical reports shared by the NIH, Graves’ disease is the most common cause of hyperthyroidism accounting for about 60% to 80% of hyperthyroid cases with an overall prevalence of hyperthyroidism of 1.2% in the US.
The market in the region of Asia Pacific is anticipated to witness substantial growth over the forecast period owing to the improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in foreign direct investments by international companies into these economies is expected to fuel the growth of the thyroid disorder market in the APAC region during the time span studied. As per the data obtained from the National Investment Promotion & Facilitation Agency, India attracted a total FDI inflow of USD 27.37 billion during the first four months of the fiscal year of 2021-22 which was 62% higher compared to the fiscal year of 2020-21.
Source – Kenneth Research
Market Segmentation
Our in-depth analysis of the global thyroid disorder market includes the following segments:
|
By Disorder Type |
|
|
By Treatment Type |
|
|
By Route of Administration |
|
|
By End User |
|
Key Companies Dominating the Global Thyroid Disorder Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global thyroid disorder market that are included in our report are AbbVie Inc., Pfizer Inc., Merck KGaA, AstraZeneca, Lannett Company, Inc., Amgen Inc., Sanofi, Viatris Inc., GlaxoSmithKline plc., Abbott Laboratories, and others.
Global Thyroid Disorder Market: Latest Developments
-
November 3, 2020: Lannett Company, Inc. launched an authorized generic of Tirosint (Levothyroxine Sodium Capsules) which is used in the treatment of thyroid deficiency.
-
June 23, 2022: Merck KgaA installed a ~USD 60 million CDMO Facility to cater to the demand for critical cancer therapies which doubles the production of the most highly potent active pharmaceutical ingredients (HPAPIs) that are effective against cancer.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.
-
We provide customized reports as per the client's requirements helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goals.
Frequently Asked Question
The market is segmented by disorder type, treatment type, route of administration, end-user, and by region.
The hypothyroidism segment is anticipated to garner the largest market size by the end of 2031 and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10352405 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
